British Journal of DOI:10.1111/bph.13387 BJP www.brjpharmacol.org Pharmacology RESEARCH PAPER Correspondence Dr Robin S. Bon and Professor David J. Beech, School of Medicine, University of Leeds, LIGHT Building, Clarendon Natural and synthetic Way, Leeds, LS2 9JT, UK. E-mail:
[email protected]; d.j. flavonoid modulation of
[email protected] *These authors contributed equally. --------------------------------------------------------- TRPC5 channels Received 14 July 2015 Jacqueline Naylor1, Aisling Minard2*, Hannah J Gaunt1*, Mohamed S Revised Amer1,3, Lesley AWilson1,MarcoMigliore2,SinYCheung1,HusseinN 14 October 2015 Accepted Rubaiy1,NicolaMBlythe1, Katie E Musialowski1, Melanie J Ludlow1, 20 October 2015 William D Evans2, Ben L Green1,HongjunYang4,YunYou4,JingLi1, Colin W G Fishwick2, Katsuhiko Muraki5,DavidJBeech1 and Robin S Bon1,2 1School of Medicine, University of Leeds, Leeds LS2 9JT, UK, 2School of Chemistry, University of Leeds, Leeds LS2 9JT, UK, 3Clinical Physiology Department, Faculty of Medicine, Menoufiya University, Shibin Al Kawm, Egypt, 4Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China, and 5School of Pharmacy, Aichi-Gakuin University, Nagoya 464–8650, Japan BACKGROUND AND PURPOSE The TRPC5 proteins assemble to create calcium-permeable, non-selective, cationic channels. We sought novel modulators of these channels through studies of natural products. EXPERIMENTAL APPROACH Intracellular calcium measurements and patch clamp recordings were made from cell lines. Compounds were generated by synthetic chemistry. KEY RESULTS Through a screen of natural products used in traditional Chinese medicines, the flavonol galangin was identified as an inhibitor of μ lanthanide-evoked calcium entry in TRPC5 overexpressing HEK 293 cells (IC50 0.45 M).